Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
measure. Data are now available and the change needed for true change is provided. Patients with SCH and unremitting TSH above 10 mU/L have increased risk of a cardiovascular event and mortality in observational studies [ 21 ]. Thus, patients with this
Search for other papers by Estefanía Rinaldini in
Google Scholar
PubMed
Search for other papers by Fiorella Campo Verde Arboccó in
Google Scholar
PubMed
Search for other papers by Marcelo Ezquer in
Google Scholar
PubMed
Facultad de Ciencias Médicas, Instituto de Fisiología, Universidad Nacional de Cuyo, Mendoza, Argentina
Search for other papers by Carlos Gamarra-Luques in
Google Scholar
PubMed
Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Cuyo, Mendoza, Argentina
Search for other papers by María Belén Hapon in
Google Scholar
PubMed
Introduction Thyroid diseases cause menstrual disturbances, reduced fertility, recurrent pregnancy loss, perinatal mortality, and lactational deficit [ 1 , 2 ]. We have demonstrated that hypothyroidism delays the onset of parturition, reduces
Search for other papers by Yuwei Liu in
Google Scholar
PubMed
Search for other papers by Shengcai Wang in
Google Scholar
PubMed
Search for other papers by Yanzhen Li in
Google Scholar
PubMed
Search for other papers by Xuexi Zhang in
Google Scholar
PubMed
Search for other papers by Zhiyong Liu in
Google Scholar
PubMed
Search for other papers by Qiaoyin Liu in
Google Scholar
PubMed
Search for other papers by Nian Sun in
Google Scholar
PubMed
Search for other papers by Jie Zhang in
Google Scholar
PubMed
Search for other papers by Wentong Ge in
Google Scholar
PubMed
Search for other papers by Yongli Guo in
Google Scholar
PubMed
Search for other papers by Yuanhu Liu in
Google Scholar
PubMed
Search for other papers by Xiaolian Fang in
Google Scholar
PubMed
Search for other papers by Tingting Ji in
Google Scholar
PubMed
Search for other papers by Jun Tai in
Google Scholar
PubMed
Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health (NCCH), Beijing, China
Search for other papers by Xin Ni in
Google Scholar
PubMed
the mortality is about 0.02 deaths per 1,00,000 persons [ 1 ]. An analysis based on the surveillance, epidemiology, and end results database and revealed the annual incidence of DTC was 0.54 cases per 1,00,000 persons in children [ 2 ], and it was
Search for other papers by Beng Khiong Yap in
Google Scholar
PubMed
Search for other papers by Jarrod Homer in
Google Scholar
PubMed
Search for other papers by Neil Parrott in
Google Scholar
PubMed
Search for other papers by Sean Loughran in
Google Scholar
PubMed
Search for other papers by Brian Murby in
Google Scholar
PubMed
Search for other papers by Ric Swindell in
Google Scholar
PubMed
Search for other papers by Ashu Gandhi in
Google Scholar
PubMed
recommend total or near-total thyroidectomy for differentiated thyroid carcinoma (DTC) of >1 cm [ 5 , 6 ]. Although the surgical mortality associated with thyroidectomy is low [ 2 ], the potential long-term complications of recurrent laryngeal nerve palsy
Search for other papers by Fabián Pitoia in
Google Scholar
PubMed
Search for other papers by Fernando Jerkovich in
Google Scholar
PubMed
Search for other papers by Anabella Smulever in
Google Scholar
PubMed
Search for other papers by Gabriela Brenta in
Google Scholar
PubMed
Search for other papers by Fernanda Bueno in
Google Scholar
PubMed
Search for other papers by Graciela Cross in
Google Scholar
PubMed
Introduction Various staging systems have historically been used to assess the risk of mortality in patients with differentiated thyroid cancer (DTC) [ 1 , 2 , 3 , 4 , 5 ]. All of them are strongly dependent on patient age since age at
Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Min Gyu Kim in
Google Scholar
PubMed
Search for other papers by Min Soo Kim in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
characterized by a rapid increase in incidence and a reduced mortality rate, which is thought to have resulted from the increase in diagnostic sensitivity due to advances in diagnostic technology, including ultrasonography ( 4 , 5 ). This trend has led to an
Search for other papers by Bruno Bouça in
Google Scholar
PubMed
Search for other papers by Ana Cláudia Martins in
Google Scholar
PubMed
Search for other papers by Paula Bogalho in
Google Scholar
PubMed
Search for other papers by Lídia Sousa in
Google Scholar
PubMed
Search for other papers by Tiago Bilhim in
Google Scholar
PubMed
Search for other papers by Filipe Veloso Gomes in
Google Scholar
PubMed
Search for other papers by Élia Coimbra in
Google Scholar
PubMed
Search for other papers by Ana Agapito in
Google Scholar
PubMed
Search for other papers by José Silva-Nunes in
Google Scholar
PubMed
, thus, a major cause of morbidity and mortality. Amiodarone is widely considered to be the most effective antiarrhythmic drug, even for the CHD population. Treatment with this class III anti-arrhythmic drug is commonly used in these patients as it is
Search for other papers by Oleksiy Tsybrovskyy in
Google Scholar
PubMed
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by Giovanni Tallini in
Google Scholar
PubMed
& Franklyn JA . Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up . Journal of Clinical Endocrinology and
Department of Endocrinology and Diabetes, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
Search for other papers by Saleha Babli in
Google Scholar
PubMed
Search for other papers by Richard J. Payne in
Google Scholar
PubMed
Search for other papers by Elliot Mitmaker in
Google Scholar
PubMed
Search for other papers by Juan Rivera in
Google Scholar
PubMed
study by Kashima et al. [ 5 ] reported a 0.7% cancer-specific mortality rate and a 95% relapse-free 10-year survival rate in patients with CLT compared to a 5% mortality and 85% relapse-free 10-year survival rate for those without CLT. Furthermore, CLT
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Thomas Brix in
Google Scholar
PubMed
Search for other papers by Marianne Vogsen in
Google Scholar
PubMed
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Search for other papers by Peter Grupe in
Google Scholar
PubMed
Search for other papers by Jeanette Krogh Petersen in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
increased risk of thyroid cancer (TC) [ 8 , 9 ], although surveillance bias may, at least partly, explain the latter. Whether GD, which is associated with excess mortality [ 10 ], affects the prognosis of differentiated TC is still a matter of controversy